|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1994-5-9
|
|
pubmed:abstractText |
To investigate the nature of the target epitope for human immunodeficiency virus (HIV) and chlorpromazine (CPZ) induced antiphospholipid antibodies (aPL) by evaluating the effect of the aPL cofactor (beta 2 glycoprotein I) on phospholipid binding and to compare this with known binding patterns of infection induced and autoimmune aPL.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
94-9
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8151598-Antibodies, Antiphospholipid,
pubmed-meshheading:8151598-Apolipoproteins,
pubmed-meshheading:8151598-Autoimmunity,
pubmed-meshheading:8151598-Chlorpromazine,
pubmed-meshheading:8151598-Glycoproteins,
pubmed-meshheading:8151598-HIV Infections,
pubmed-meshheading:8151598-Humans,
pubmed-meshheading:8151598-Immunoglobulin G,
pubmed-meshheading:8151598-Immunoglobulin M,
pubmed-meshheading:8151598-Phospholipids,
pubmed-meshheading:8151598-beta 2-Glycoprotein I
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
|
|
pubmed:affiliation |
Antiphospholipid Research Laboratory, New Orleans 70112.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
